BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 17910426)

  • 21. Synthesis and biological evaluation of amino-substituted benzo[f]pyrido[4,3-b] and pyrido[3,4-b]quinoxalines: a new class of antineoplastic agents.
    Nguyen CH; Fan E; Riou JF; Bissery MC; Vrignaud P; Lavelle F; Bisagni E
    Anticancer Drug Des; 1995 Jun; 10(4):277-97. PubMed ID: 7786395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and evaluation of the antiproliferative activity of novel isoindolo[2,1-a]quinoxaline and indolo[1,2-a]quinoxaline derivatives.
    Desplat V; Moreau S; Belisle-Fabre S; Thiolat D; Uranga J; Lucas R; de Moor L; Massip S; Jarry C; Mossalayi DM; Sonnet P; Déléris G; Guillon J
    J Enzyme Inhib Med Chem; 2011 Oct; 26(5):657-67. PubMed ID: 21250818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New quinoxaline 1, 4-di-N-oxides: anticancer and hypoxia-selective therapeutic agents.
    Ismail MM; Amin KM; Noaman E; Soliman DH; Ammar YA
    Eur J Med Chem; 2010 Jul; 45(7):2733-8. PubMed ID: 20236735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and in vitro evaluation of new ethyl and methyl quinoxaline-7-carboxylate 1,4-di-N-oxide against Entamoeba histolytica.
    Duque-Montaño BE; Gómez-Caro LC; Sanchez-Sanchez M; Monge A; Hernández-Baltazar E; Rivera G; Torres-Angeles O
    Bioorg Med Chem; 2013 Aug; 21(15):4550-8. PubMed ID: 23787289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and cytotoxicity of 2-methyl-4, 9-dihydro-1-substituted-1H-imidazo[4,5-g]quinoxaline-4,9-diones and 2,3-disubstituted-5,10-pyrazino[2,3-g]quinoxalinediones.
    Yoo HW; Suh ME; Park SW
    J Med Chem; 1998 Nov; 41(24):4716-22. PubMed ID: 9822542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytotoxic palladium complexes of bioreductive quinoxaline N1,N4-dioxide prodrugs.
    Urquiola C; Vieites M; Torre MH; Cabrera M; Lavaggi ML; Cerecetto H; González M; Cerain AL; Monge A; Smircich P; Garat B; Gambino D
    Bioorg Med Chem; 2009 Feb; 17(4):1623-9. PubMed ID: 19162490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and biological evaluation of new geiparvarin derivatives.
    Chimichi S; Boccalini M; Salvador A; Dall'Acqua F; Basso G; Viola G
    ChemMedChem; 2009 May; 4(5):769-79. PubMed ID: 19322800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective activity against Mycobacteriumtuberculosis of new quinoxaline 1,4-di-N-oxides.
    Vicente E; Pérez-Silanes S; Lima LM; Ancizu S; Burguete A; Solano B; Villar R; Aldana I; Monge A
    Bioorg Med Chem; 2009 Jan; 17(1):385-9. PubMed ID: 19058970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and biological evaluation of imidazoquinoxalinones, imidazole analogues of pyrroloiminoquinone marine natural products.
    Hoang H; LaBarbera DV; Mohammed KA; Ireland CM; Skibo EB
    J Med Chem; 2007 Sep; 50(19):4561-71. PubMed ID: 17705462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis, and in vitro antitumor activity of new 1,4-diarylimidazole-2-ones and their 2-thione analogues.
    Congiu C; Cocco MT; Onnis V
    Bioorg Med Chem Lett; 2008 Feb; 18(3):989-93. PubMed ID: 18164978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and structure-activity relationship of 3-phenylquinoxaline 1,4-di-N-oxide derivatives as antimalarial agents.
    Vicente E; Lima LM; Bongard E; Charnaud S; Villar R; Solano B; Burguete A; Perez-Silanes S; Aldana I; Vivas L; Monge A
    Eur J Med Chem; 2008 Sep; 43(9):1903-10. PubMed ID: 18215443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New quinoxalinecarbonitrile 1,4-di-N-oxide derivatives as hypoxic-cytotoxic agents.
    Ortega MA; Morancho MJ; Martínez-Crespo FJ; Sainz Y; Montoya ME; López de Ceráin A; Monge A
    Eur J Med Chem; 2000 Jan; 35(1):21-30. PubMed ID: 10733600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 1, 2, 4-Triazine N-oxide derivatives: studies as potential hypoxic cytotoxins. Part II.
    Cerecetto H; González M; Onetto S; Saenz P; Ezpeleta O; De Ceráin AL; Monge A
    Arch Pharm (Weinheim); 2004 May; 337(5):247-58. PubMed ID: 15095418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 3-Trifluoromethylquinoxaline N,N'-dioxides as anti-trypanosomatid agents. Identification of optimal anti-T. cruzi agents and mechanism of action studies.
    Benitez D; Cabrera M; Hernández P; Boiani L; Lavaggi ML; Di Maio R; Yaluff G; Serna E; Torres S; Ferreira ME; Vera de Bilbao N; Torres E; Pérez-Silanes S; Solano B; Moreno E; Aldana I; López de Ceráin A; Cerecetto H; González M; Monge A
    J Med Chem; 2011 May; 54(10):3624-36. PubMed ID: 21506600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological evaluation of 2,4,6-functionalized derivatives of pyrido[2,3-d]pyrimidines as cytotoxic agents and apoptosis inducers.
    Sanmartín C; Domínguez MV; Cordeu L; Cubedo E; García-Foncillas J; Font M; Palop JA
    Arch Pharm (Weinheim); 2008 Jan; 341(1):28-41. PubMed ID: 18161903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quinoxaline chemistry. Part 8. 2-[Anilino]-3-[carboxy]-6(7)-substituted quinoxalines as non classical antifolate agents. Synthesis and evaluation of in vitro anticancer, anti-HIV and antifungal activity.
    Loriga M; Moro P; Sanna P; Paglietti G; Zanetti S
    Farmaco; 1997; 52(8-9):531-7. PubMed ID: 9507661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aziridinyldinitrobenzamides: synthesis and structure-activity relationships for activation by E. coli nitroreductase.
    Helsby NA; Atwell GJ; Yang S; Palmer BD; Anderson RF; Pullen SM; Ferry DM; Hogg A; Wilson WR; Denny WA
    J Med Chem; 2004 Jun; 47(12):3295-307. PubMed ID: 15163209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and biological evaluation of spin-labeled alkylphospholipid analogs.
    Mravljak J; Zeisig R; Pecar S
    J Med Chem; 2005 Oct; 48(20):6393-9. PubMed ID: 16190765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and biological evaluation of imidazol-2-one derivatives as potential antitumor agents.
    Xue N; Yang X; Wu R; Chen J; He Q; Yang B; Lu X; Hu Y
    Bioorg Med Chem; 2008 Mar; 16(5):2550-7. PubMed ID: 18226907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New quinoxaline 1,4-di-N-oxides for treatment of tuberculosis.
    Sainz Y; Montoya ME; Martínez-Crespo FJ; Ortega MA; López de Ceráin A; Monge A
    Arzneimittelforschung; 1999 Jan; 49(1):55-9. PubMed ID: 10028381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.